Clinical trial
Prospective Control Study of TW in the Treatment of LN Type V With Gross Proteinuria
NCT00935389 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Control Study of TW in the Treatment of LN Type V With Gross Proteinuria
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- May 31, 2011
- Enrollment
- 44 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ctx, lupus nephritis, proteinuria